Congratulations to CuePath Innovation, a 2016 Top 10 competitor, who just announced that they have raised $1.8M in seed funding, and received $750,000 in funding from Genome BC!
The seed funding comes from E-Fund, Canada Innovation Acceleration Investment, and a group of angel investors. Genome BC‘s investment is staged, and come through their Industry Innovation (I²) Program. The program provides commercialization support for companies developing innovative life science technologies that address biological challenges in key economic sectors in BC.
Along with the seed funding, Genome BC’s investment in CuePath will be used “to support marketing and sales activities, expand clinical trials and subsequent market entry into North America in 2018,” said Dr. Tony Brooks, Chief Financial Officer and Vice President, Commercialization and Entrepreneurship of Genome BC.
Reproduced from Newswire and Geekwire.
